IL13 and glioblastoma: For example, β-emitters and TAMRA-labeled IL-13 peptides conjugated to the radiolanthanide lutetium (177Lu) encapsulated C80 fullerene cage (177LuxLu(3-x) N@C80), which can show potential therapeutic properties toward GBM [48].